Improving the adjuvant treatment of HER2-positive breast cancer: APHINITY and ExteNET trials by Noam Pondé, Evandro de Azambuja

Get full text

Brazilian medical oncologists: current and future perspectives for 2020 by Júlia Plentz Portich, Juliana Giacomazzi, Alessandra Menezes Morelle, Daniela Dornelles Rosa, José Roberto Freitas Rossari, Evandro de Azambuja

Get full text

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy by C. Florin Pop, Clémence Ortega, Mathilde Lecomte, Paulus Kristanto, Chirine Khaled, Filip De Neubourg, Antoine Desmet, Evandro De Azambuja, Denis Larsimont, Isabelle Veys

Get full text

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study by Karen Van Baelen, Ha-Linh Nguyen, François Richard, Gitte Zels, Maria Margarete Karsten, Guilherme Nader-Marta, Peter Vermeulen, Luc Dirix, Adam David Dordevic, Evandro de Azambuja, Denis Larsimont, Marion Maetens, Elia Biganzoli, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Giuseppe Floris, Christine Desmedt

Get full text